Organisation paid for research Program year 2023 Source: CMS Open Payments

Visionaries Clinical Research LLC

Neither a doctor nor a teaching hospital

Research payments

$446,730

51 payments

Through program year 2023, Visionaries Clinical Research LLC is reported as receiving $446,730 in research payments, across 51 payments.

By program year

3 rows
Year Kind Amount Payments
2023 Research $91,657 23
2022 Research $338,610 21
2021 Research $16,463 7

Breakdown

Who paid Research payments · program years 2021–2023
  1. Global Blood Therapeutics, Inc. $247,569 8 payments
  2. Evofem Biosciences, Inc. $100,771 23 payments
  3. Pfizer Inc. $58,890 5 payments
  4. Bausch Health US, LLC $39,500 15 payments
Studies the money was for Research payments · program years 2021–2023
  1. The purpose of this study is to evaluate the safety, tolerability, and pharmacokinetics (PK), and pharmacodynamics (i.e., how the body absorbs, distributes, breaks down, and excretes) of GBT021601, a hemoglobin S (HbS) polymerization inhibitor, in participants with SCD, following single and multiple ascending doses. $247,569 8 payments
  2. Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection (EVOGUARD) $84,308 16 payments
  3. An Intrapatient Single Dose and Multiple Ascending Dose Study to Evaluate the Pharmacokinetics Safety Tolerability and Pharmacodynamics of Gbt021601 A Hemoglobin S Polymerization Inhibitor in Participants With Sickle Cell Disease SCD $58,890 5 payments
  4. A Phase 2a Randomized, Double-Blind, Placebo-Controlled Study to Characterize the Pharmacokinetics and Pharmacodynamics of Rifaximin Novel Formulations in Patients with Sickle Cell Disease $39,500 15 payments
  5. Evaluation of EVO100 for Prevention of Urogenital Chlamydia Trachomatis and Neisseria Gonorrhoeae Infection $16,463 7 payments
What the money was spent on Research payments · program years 2021–2023
  1. Professional salary support $92,504 19 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record